Horng H Chen Selected Research

Horng H Chen Research Topics

Disease

59	Heart Failure 01/2022 - 02/2002
13	Hypertension (High Blood Pressure) 01/2022 - 10/2006
7	Fibrosis (Cirrhosis) 01/2022 - 02/2011
4	Weight Loss (Weight Reduction) 01/2022 - 12/2012
4	Inflammation (Inflammations) 08/2020 - 03/2015
4	Cardiovascular Diseases (Cardiovascular Disease) 06/2015 - 08/2005
4	Hypotension (Low Blood Pressure) 10/2014 - 01/2008
3	Left Ventricular Dysfunction 01/2022 - 09/2010
3	Diastolic Heart Failure 01/2017 - 10/2002
3	Systolic Heart Failure 01/2016 - 12/2012
2	Myocardial Infarction 01/2021 - 08/2013
2	Disease Progression 01/2019 - 12/2006
2	Atrial Fibrillation 01/2017 - 04/2010
2	Necrosis 01/2017 - 03/2015
2	Dyspnea (Shortness of Breath) 02/2016 - 12/2011
2	Azotemia 01/2016 - 01/2008
2	Cardio-Renal Syndrome 01/2016 - 12/2011
2	Erectile Dysfunction 08/2014 - 10/2006
2	Coronary Artery Disease (Coronary Atherosclerosis) 04/2010 - 06/2006
1	Reperfusion Injury 08/2020
1	Insulin Resistance 06/2020
1	Obesity 06/2020
1	Ventricular Remodeling 01/2019
1	Cardiomyopathies (Cardiomyopathy) 11/2018
1	Hypertensive Crisis 06/2018
1	Acute Kidney Injury (Acute Renal Failure) 06/2018
1	Breast Neoplasms (Breast Cancer) 08/2017
1	Diabetes Mellitus 01/2017
1	Right Ventricular Dysfunction 01/2017
1	Pulmonary Hypertension 08/2014
1	Infarction (Infarctions) 08/2013
1	Body Weight (Weight, Body) 12/2012
1	Prehypertension 10/2012
1	Proteinuria 01/2012
1	Hyponatremia 12/2011

Drug/Important Bio-Agent (IBA)

35	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021 - 02/2002
15	Natriuretic PeptidesIBA 06/2020 - 02/2002
11	Atrial Natriuretic Factor (ANF)IBA 01/2022 - 05/2005
10	Biomarkers (Surrogate Marker)IBA 08/2020 - 04/2006
10	DiureticsIBA 01/2016 - 02/2002
8	AldosteroneIBA 01/2022 - 04/2004
6	Dopamine (Intropin)FDA LinkGeneric 01/2016 - 12/2011
6	Angiotensin IIIBA 01/2014 - 05/2003
5	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2022 - 10/2006
5	Furosemide (Lasix)FDA LinkGeneric 01/2022 - 04/2004
4	Proteins (Proteins, Gene)FDA Link 08/2020 - 01/2007
4	Hormones (Hormone)IBA 01/2020 - 04/2004
4	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 01/2018 - 03/2011
4	Sildenafil Citrate (Viagra)FDA Link 01/2017 - 10/2006
4	CreatinineIBA 01/2016 - 09/2007
4	AngiotensinsIBA 07/2009 - 01/2004
3	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 01/2021 - 02/2011
3	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2018 - 04/2004
3	Antihypertensive Agents (Antihypertensives)IBA 03/2015 - 01/2007
3	ReninIBA 07/2009 - 02/2002
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2019
2	Cystatin CIBA 03/2015 - 02/2011
2	Soluble Guanylyl CyclaseIBA 08/2014 - 01/2014
2	pro-brain natriuretic peptide (1-76)IBA 10/2012 - 10/2006
2	Peptides (Polypeptides)IBA 07/2009 - 11/2006
2	SodiumIBA 01/2008 - 01/2004
1	Tadalafil (Cialis)FDA Link 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2022
1	Annexin A1IBA 08/2020
1	Glucose (Dextrose)FDA LinkGeneric 06/2020
1	Biological ProductsIBA 01/2020
1	atrial natriuretic factor receptor AIBA 01/2020
1	NitritesIBA 11/2018
1	cenderitideIBA 01/2018
1	Cyclic GMPIBA 01/2018
1	ChloridesIBA 01/2017
1	omega-Chloroacetophenone (Mace)IBA 11/2016
1	insulin-like growth factor binding protein-related protein 1IBA 11/2016
1	Oxygen (Dioxygen)IBA 02/2016
1	NitratesIBA 12/2015
1	isosorbide-5-mononitrate (Ismo)FDA LinkGeneric 12/2015
1	Galectin 3 (LGALS3)IBA 03/2015
1	Phosphodiesterase 5 InhibitorsIBA 08/2014
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2014
1	riociguatIBA 08/2014
1	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2014
1	Guanylate Cyclase (Guanylyl Cyclase)IBA 01/2014
1	salicylhydroxamic acid (SHAM)IBA 01/2012
1	CollagenIBA 01/2012
1	Antidiuretic Hormone Receptor AntagonistsIBA 12/2011
1	Phosphodiesterase InhibitorsIBA 12/2011
1	Adenosine (Adenocard)FDA LinkGeneric 12/2011
1	procollagen Type III-N-terminal peptide (PIIP)IBA 04/2011
1	Neurotransmitter Agents (Neurotransmitter)IBA 04/2011
1	Indicators and Reagents (Reagents)IBA 02/2011

Therapy/Procedure

23	Therapeutics 01/2022 - 02/2002
4	Patient Readmission 01/2022 - 10/2007
2	Cardiac Resynchronization Therapy 01/2019 - 04/2011
2	Nephrectomy 01/2012 - 01/2012
1	Length of Stay 06/2018
1	Radiotherapy 08/2017
1	Drug Tapering 12/2014
1	Subcutaneous Infusions 01/2012
1	Drug Therapy (Chemotherapy) 12/2011